Related Experiment Videos
Clinical and metabolic studies with imipramine in man
The American Journal of Psychiatry
|April 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Systemic lupus erythematosus : Unusual cutaneous manifestations].
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2016
Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
Archives of general psychiatry·2003
2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists·2001
Correlations between motor persistence and plasma levels in methylphenidate-treated boys with ADHD.
The international journal of neuropsychopharmacology·2001
Serum fluvoxamine levels in breastfed infants.
The Journal of clinical psychiatry·2001
The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions.
The American journal of psychiatry·2026
Hippocampal Dentate Gyrus Plasticity and Its Association With Dimensional Clinical Improvement Across Four Depression Treatment Interventions.
The American journal of psychiatry·2026
Association Between Age-Dependent DNA Methylation Changes at FKBP5 Enhancer Sites and Increased Cortical Gene Expression in Schizophrenia.
The American journal of psychiatry·2026
Youth Autistic Traits and Brain Activation States During Socioemotional Processing.
The American journal of psychiatry·2026
Schizophrenia Beyond Genome-Wide Association Studies: It's About Time.
The American journal of psychiatry·2026
Population Pharmacokinetic and Pharmacodynamic Analysis of Imipenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.
Drug design, development and therapy·2026
Medication Safety and Perioperative Risk Management of GLP-1 Receptor Agonists: A Pharmacist-Led Framework for Individualized Care.
Therapeutics and clinical risk management·2026
GLP-1 and GIP class drugs have neuroprotective properties in Alzheimer's and Parkinson's disease.
Frontiers in neuroscience·2026
Multidimensional characterization of heterogeneity in pesticide co-exposure patterns.
Frontiers in chemistry·2026
Frustration brake failure hypothesis of substance use disorders.
Frontiers in psychiatry·2026